Private Advisor Group LLC Acquires Shares of 5,877 Invesco Pharmaceuticals ETF $PJP

Private Advisor Group LLC acquired a new stake in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 5,877 shares of the company’s stock, valued at approximately $610,000.

Several other large investors have also recently made changes to their positions in PJP. Flagship Harbor Advisors LLC lifted its position in shares of Invesco Pharmaceuticals ETF by 1.8% in the fourth quarter. Flagship Harbor Advisors LLC now owns 6,049 shares of the company’s stock worth $632,000 after buying an additional 105 shares in the last quarter. IFP Advisors Inc boosted its position in shares of Invesco Pharmaceuticals ETF by 31.3% during the 4th quarter. IFP Advisors Inc now owns 440 shares of the company’s stock valued at $46,000 after acquiring an additional 105 shares during the last quarter. J.W. Cole Advisors Inc. boosted its position in shares of Invesco Pharmaceuticals ETF by 4.7% during the 4th quarter. J.W. Cole Advisors Inc. now owns 2,910 shares of the company’s stock valued at $304,000 after acquiring an additional 131 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Invesco Pharmaceuticals ETF by 5.7% in the third quarter. Northwestern Mutual Wealth Management Co. now owns 2,791 shares of the company’s stock valued at $258,000 after purchasing an additional 150 shares in the last quarter. Finally, Rockefeller Capital Management L.P. grew its holdings in shares of Invesco Pharmaceuticals ETF by 20.5% in the fourth quarter. Rockefeller Capital Management L.P. now owns 1,230 shares of the company’s stock valued at $129,000 after purchasing an additional 209 shares in the last quarter.

Invesco Pharmaceuticals ETF Stock Performance

Shares of PJP opened at $117.08 on Thursday. The stock has a market capitalization of $353.58 million, a PE ratio of 15.59 and a beta of 0.45. The company’s fifty day moving average is $112.41 and its 200 day moving average is $107.90. Invesco Pharmaceuticals ETF has a fifty-two week low of $80.63 and a fifty-two week high of $122.69.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.